Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: Role of NO and prostanoids

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 10, 2011, Pages 808-816

  Lobato, N S ^a   Filgueira, F P ^a   Akamine, E H ^a   Davel, A P C ^a   Rossoni, L V ^a   Tostes, R C ^a   Carvalho, M H C ^a   Fortes, Z B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Mesenteric arteriolar bed; Monosodium glutamate; Nitric oxide; Obesity; Prostanoids; Reactive oxygen species

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMATE SODIUM; NITRIC OXIDE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTERIOLE; ARTICLE; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; MALE; MESENTERY; METABOLISM; MICROVASCULATURE; NEWBORN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ARTERIOLES; CYCLOOXYGENASE 2; MALE; MESENTERY; MICROVESSELS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PROSTAGLANDINS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SODIUM GLUTAMATE;

RATTUS; RATTUS NORVEGICUS;

EID: 80053052724     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.02.006     Document Type: Article

References (43)

1. Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
2. Hill J.O. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 2006, 27:750-761.
3. Echahidi N., Mohty D., Pibarot P., Després J.P., O'hara G., Champagne J., et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007, 116(11):I213-I219.
4. Stapleton P.A., James M.E., Goodwill A.G., Frisbee J.C. Obesity and vascular dysfunction. Pathophysiology 2008, 15(2):79-89.
5. Barton M., Furrer J. Cardiovascular consequences of the obesity pandemic: need for action. Expert Opin Investig Drugs 2003, 12:1757-1759.
6. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
7. Hirata A.E., Andrade I.S., Vaskevicius P., Dolnikoff M.S. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 1997, 30:671-674.
8. Tokarev D., Kristová V., Kriska M., Jezová D. Treatment of neonatal rats with monosodium glutamate attenuates the cardiovascular reactivity to phenylephrine and angiotensin II. Physiol Res 1997, 46(3):165-171.
9. Dawson R., Pelleymounter M.A., Millard W.J., Liu S., Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997, 273:E202-E206.
10. Macho L., Fickova M., Jezova, Zorad S. Late effects of postnatal administration of monosodium glutamate on insulin action in adult rats. Physiol Res 2000, 49:S79-S85.
11. Messina M.M., Evans A.S., Swoap S.J., Overton J.M. Perinatal MSG treatment attenuates fasting-induced bradycardia and metabolic suppression. Physiol Behav 2005, 86:324-330.
12. Tokuyama K., himms-hagen J. Adrenalectomy prevents obesity in glutamate-treated mice. Am J Physiol 1989, 237:E139-E144.
13. Dolnikoff M., Martín-Hidalgo A., Machado U.F., Lima F.B., Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord 2001, 25(3):426-433.
14. Könner A.C., Klöckener T., Brüning J.C. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav 2009, 97(5):632-638.
15. Akamine E.H., Kawamoto E.M., Scavone C., Nigro D., Carvalho M.H., Tostes R.C., et al. Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J Vasc Res 2006, 43(4):309-320.
16. Matthew D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function form fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
17. Mc Gregor D.D. The effect of sympathetic nerve stimulation of vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J Physiol 1965, 177:21-30.
18. Xavier F.E., Rossoni L.V., Alonso M.J., Balfagón G., Vassallo D.V., Salaices M. Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries. Br J Pharmacol 2004, 143:215-225.
19. Kojima H., Nakatsubo N., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 1998, 70:2446-2453.
20. Suzuki H., Swei A., Zweifach B.W., Schmid-Schonbein G.W. In vivo evidence for microvascular oxidative stress in Spontaneously Hypertensive Rats. Hypertension 1995, 25:1083-1089.
21. Davel A.P., Fukuda L.E., De Sá L.L., Munhoz C.D., Scavone C., Sanz-Rosa D., et al. Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol 2008, 295(1):H211-H219.
22. De Vriese A.S., Verbeuren T.J., Voorde J.V., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br J Pharmacol 2000, 130:963-974.
23. Carvalho M.H., Scivoletto R., Fortes Z.B., Nigro D., Cordellini S. Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium. J Hypertens 1987, 5(3):377-382.
24. Moreno G., Perello M., Camihort G., Luna G., Console G., Gaillard R.C., et al. Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rat. Int J Obes 2006, 30:73-82.
25. de Carvalho Papa P., Vargas A.M., da Silva J.L., Nunes M.T., Machado U.F. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci 2002, 71(16):1917-1928.
26. Morris M.J., Tortelli C.F., Filippis A., Proietto J. Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. Regul Pept 1998, 75:441-447.
27. Ritchie S.A., Ewart M.A., Perry C.G., Connell J.M., Salt I.P. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci 2004, 107(6):519-532.
28. Perelló M., Gaillard R.C., Chisari A., Spinedi E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology 2003, 78(3):176-184.
29. Perelló M., Moreno G., Gaillard R.C., Spinedi E. Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity. Neuro Endocrinol Lett 2004, 25(1-2):119-126.
30. Lijnen H.R. Angiogenesis and obesity. Cardiovasc Res 2008, 78(2):286-293.
31. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D., Lijnen H.R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005, 146(10):4545-4554.
32. Martins A.C., Souza K.L., Shio M.T., Mathias P.C., Lelkes P.I., Garcia R.M. Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. Life Sci 2004, 74(26):3211-3222.
33. Lucinei Balbo S., Gravena C., Bonfleur M.L., de Freitas Mathias P.C. Insulin secretion and acetylcholinesterase activity in monosodium l-glutamate-induced obese mice. Horm Res 2000, 54(4):186-191.
34. Stepp D.W., Frisbee J.C. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 2002, 282:H816-H820.
35. Ghatta S., Ramarao P. Increased contractile responses to 5-hydroxytryptamine and Angiotensin II in high fat diet fed rat thoracic aorta. Lipids Health Dis 2004, 3:19.
36. Villar I.C., Francis S., Webb A., Hobbs A.J., Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 2006, 70:840-853.
37. Förstermann U., Münzel T. Endothelial nitric oxide synthase in vascular disease. Circulation 2006, 113:1708-1714.
38. Wenzel P., Daiber A., Oelze M., Brandt M., Closs E., Xu J., et al. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008, 198(1):65-76.
39. Szerafin T., Erdei N., Fulop T., Pasztor E.T., Edes I., Koller A., et al. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res 2006, 99:e12-e17.
40. Traupe T., Lang M., Goettsch W., Münter K., Morawietz H., Vetter W., et al. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 2002, 20:2239-2245.
41. Stepp D.W., Boesen E.I., Sullivan J.C., Mintz J.D., Hair C.D., Pollock D.M. Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am J Physiol Heart Circ Physiol 2007, 293(4):H2537-H2542.
42. Frisbee J.C. Impaired dilation of skeletal muscle microvessels to reduced oxygen tension in diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 2001, 281:H1568-H1574.
43. Moncada S., Rees D.D., Schulz R., Palmer R.M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991, 88:2166-2170.